Identification of a Lead small-molecule inhibitor of anthrax Lethal toxin by using fluorescence-based high-throughput screening = Identification of a Lead small-molecule inhibitor of anthrax Lethal toxin by using fluorescence-based high-throughput screening

다국어 초록 (Multilingual Abstract)

Inhalational anthrax is caused by B. anthracis, a virulent spore- forming bacterium which secretes anthrax toxins consisting of protective antigen (PA), lethal factor (LF) and edema factor (EF). LF is a Zn-dependent metalloprotease and is the main determinant in the pathogenesis of anthrax. Here we report the identification of a lead small-molecule inhibitor of anthrax lethal factor by screening an available synthetic small-molecule inhibitor library using fluorescence-based high-throughput screening (HTS) approach. Seven small molecules were found to have inhibitory effect against LF activity, among which SM157 had the highest inhibitory activity. All theses small molecule inhibitors inhibited LF in a noncompetitive inhibition mode. SM157 and SM167 are from the same family, both having an identical group complex, which is predicted to insert into S1` pocket of LF. More potent small-molecule inhibitors could be developed by modifying SM157 based on this identical group complex. [BMB reports 2011; 44(12): 811-815]

참고문헌 (Reference)

1 Turk, B. E, "The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor" 11 : 60-66, 2004

2 Duesbery, N. S, "Proteolytic inactivation of MAP kinase kinase by anthrax lethal factor" 280 : 734-737, 1998

3 Hanna, P, "On the role of macrophages in anthrax" 90 : 10198-10201, 1993

4 Schepetkin, I. A, "Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening" 49 : 5232-5244, 2006

5 Boyden, E. D, "Nalp 1b controls mouse macrophage susceptibility to anthrax lethal toxin" 38 : 240-244, 2006

6 Barrett, A. J, "Introduction: metallopeptidases and their clans. in Handbook of proteolytic enzymes" Elsevier academic press 2004

7 Janeway, Jr., C. A, "Innate immune recognition" 20 : 197-216, 2002

8 Frazier, A. A, "Inhalational anthrax" 21 : 252-258, 2006

9 Panchal, R. G, "Identification of small molecule inhibitors of anthrax lethal factor" 11 : 67-72, 2004

10 Huber, M, "Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin" 31 : 35-43, 2005

11 Copeland, R, "Enzymes: a practical introduction to structure, mechanism and data analysis (second edition)" John Wiley & Sons 2000

12 Turk, B. E, "Discovery and development of anthrax lethal factor metalloprotease inhibitor" 9 : 24-33, 2008

13 Mourez, M, "Designing a polyvalent inhibitor of anthrax toxin" 19 : 958-961, 2001

14 Pannifer, A. D, "Crystal structure of the anthrax lethal factor" 414 : 229-233, 2001

15 Peinado, J. R, "Cross-inhibition between furin and lethal factor inhibitors" 321 : 601-605, 2004

16 Tournier, J. N, "Contribution of toxins to the pathogenesis of inhalational anthrax" 90 : 555-565, 2007

17 Duesberya, N. S, "Anthrax toxins" 55 : 1599-1609, 1999

18 Shoop, W. L, "Anthrax lethal factor inhibition" 102 : 7958-7963, 2005